November 30, 2012 — A large observational study found the increased risk associated with dual antiplatelet therapy cessa ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 30, 2012
Use of Rosuvastatin Prior to Angioplasty Does Not Influence Troponin I Release Following Angioplasty
November 9, 2012 — A study found that the use of rosuvastatin prior to angioplasty did not influence the levels of ...
November 09, 2012November 9, 2012 — Bristol-Myers Squibb Co. and Pfizer Inc. announced that the reductions in stroke or systemic embolism ...
November 09, 2012
November 7, 2012 — Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved ...
November 07, 2012
November 2, 2012 — Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
November 02, 2012October 23, 2012 — A study found that a tailored therapy approach that adjusts the loading dose of clopidogrel according ...
October 23, 2012October 16, 2012 — Proteon Therapeutics Inc. has initiated enrollment in a Phase 1 clinical study of its lead product ...
October 16, 2012
October 4, 2012 — This year’s European Society of Cardiology (ESC) Congress in Munich, Germany, was a stark example of ...
October 04, 2012
October 2, 2012 — AstraZeneca has announced the results from a sub-analysis of PLATO that evaluated the effects of age ...
October 02, 2012October 2, 2012 — A novel blood thinner recently approved by the U.S. Food and Drug Administration (FDA), Pradaxa ...
October 02, 2012
October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA ...
October 01, 2012September 28, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care ...
September 28, 2012
September 25, 2012 — Men and women who undergo joint replacement procedures, as well as those who have significant ...
September 25, 2012
September 17, 2012 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report ...
September 17, 2012September 13, 2012 — Janssen Research & Development LLC announced that it has submitted the complete response to the U.S ...
September 13, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now